Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$0.18 - $0.86 $1,019 - $4,869
-5,662 Reduced 2.64%
208,498 $52,000
Q4 2021

Feb 10, 2022

SELL
$0.85 - $1.4 $17,000 - $28,000
-20,000 Reduced 8.54%
214,160 $194,000
Q3 2021

Nov 12, 2021

BUY
$1.33 - $1.77 $30,273 - $40,288
22,762 Added 10.77%
234,160 $312,000
Q2 2021

Aug 06, 2021

SELL
$1.41 - $1.94 $28,710 - $39,502
-20,362 Reduced 8.79%
211,398 $303,000
Q1 2021

May 10, 2021

BUY
$1.61 - $2.77 $38,900 - $66,928
24,162 Added 11.64%
231,760 $418,000
Q4 2020

Feb 10, 2021

BUY
$1.55 - $2.24 $192,175 - $277,724
123,984 Added 148.28%
207,598 $365,000
Q3 2020

Nov 13, 2020

BUY
$1.91 - $3.08 $42,020 - $67,760
22,000 Added 35.71%
83,614 $165,000
Q2 2020

Aug 10, 2020

BUY
$1.97 - $3.98 $9,850 - $19,900
5,000 Added 8.83%
61,614 $172,000
Q1 2020

May 21, 2020

SELL
$1.17 - $3.0 $980 - $2,514
-838 Reduced 1.46%
56,614 $170,000
Q4 2019

Feb 14, 2020

SELL
$1.16 - $1.42 $3,479 - $4,260
-3,000 Reduced 4.96%
57,452 $69,000
Q3 2019

Nov 12, 2019

SELL
$1.21 - $1.65 $1,210 - $1,650
-1,000 Reduced 1.63%
60,452 $79,000
Q2 2019

Aug 13, 2019

BUY
$1.39 - $2.03 $26,760 - $39,081
19,252 Added 45.62%
61,452 $104,000
Q4 2018

Feb 14, 2019

BUY
$1.41 - $2.16 $1,128 - $1,728
800 Added 1.93%
42,200 $57,000
Q3 2018

Nov 09, 2018

BUY
$1.86 - $2.18 $186 - $218
100 Added 0.24%
41,400 $87,000
Q2 2018

Aug 14, 2018

BUY
$1.76 - $2.79 $7,216 - $11,439
4,100 Added 11.02%
41,300 $82,000
Q2 2017

Aug 14, 2017

BUY
N/A
37,200
37,200 $58,000

About ATHERSYS, INC


  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.